Ring finger protein 214 (RF214): A Potential Drug Target and Biomarker

Target Name: RNF214

NCBI ID: G257160

RNF214

Ring finger protein 214 (RF214): A Potential Drug Target and Biomarker

Introduction

Ring finger protein 214 (RF214) is a gene that encodes a protein located in the ring finger region of chromosome 5. It is a non-coding RNA molecule that has been shown to play a critical role in various cellular processes, including cell adhesion, migration, and signaling pathways. Despite its importance, little is known about RF214 beyond its expression and localization in the nucleus. However, recent studies have identified potential drug targets and biomarkers associated with RF214, making it an attractive molecule for further investigation.

The Ring Finger Protein 214 (RF214)

RF214 is a 21-kDa protein that contains 105 amino acid residues. It is predominantly localized to the nuclear envelope, where it is involved in various cellular processes, including the regulation of protein stability and localization to the cytoplasm. The protein is composed of two distinct isoforms, which are generated by alternative splicing of the gene. The most abundant is the long isoform, which contains all 105 amino acid residues, while the other isoform, known as the short isoform, contains only 92 amino acid residues.

Expression and localization

RNA expression of RF214 is highly specific to the cell type and developmental stage. In various tissues and cell types, RF214 is expressed at different levels, including highest and lowest expression levels. It also has different expression patterns in different stages of the cell cycle, with higher expression levels in the G1 phase, G2 phase and M phase, and lower expression levels in the G0 phase. In addition, the localization of RF214 in the nucleus has also been confirmed. It is highly expressed in the nucleolus of the nucleus, but the expression level in the cytoplasm is low.

Functions and interactions

RF214 is an important transcription factor involved in regulating the expression of multiple genes. It has been found that RF214 can interact with a variety of proteins, including histone-modified proteins such as H2A.L12, H2A.L26 and H2A.L30. These protein modifications can affect the stability of RF214, thereby affecting its function. In addition, RF214 also binds to DNA and participates in the DNA-binding transcription process.

pharmacological significance

RF214 is a potential drug target. Because of its expression and localization in the nucleus, as well as its role in the transcription process, studying RF214 may help develop new anti-tumor drugs. It has been found that some anti-tumor drugs can inhibit the expression and function of RF214, thereby leading to cell apoptosis. In addition, some studies have also shown that the immune evasion of tumor cells can be improved by regulating the expression level of RF214.

as biomarkers

In addition to being a drug target, RF214 also has potential as a biomarker. Because of its high expression level in tumor cells, it can be used to detect tumor progression and treatment effects. Some studies have shown that RF214 can be used as a biomarker for the treatment of colorectal cancer and is positively correlated with treatment efficacy.

in conclusion

RF214 is a protein expressed and localized in the nucleus, and it is expressed in different stages of the cell cycle and in different cell types. It also interacts with a variety of proteins and participates in the DNA-binding transcription process. In addition, it can serve as a potential drug target and biomarker. With the deepening of research, RF214 is expected to provide new ideas and strategies for the treatment of various tumors.

Protein Name: Ring Finger Protein 214

The "RNF214 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNF214 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets